Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1 (5-Year IF – 2.0)
Journal Citation Indicator (JCI) (2023) – 0.4
Scopus CiteScore – 3.7 (CiteScore Tracker 3.8)
Index Copernicus  – 171.00; MNiSW – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2020, vol. 29, nr 11, November, p. 1363–1366

doi: 10.17219/acem/111810

Publication type: original article

Language: English

License: Creative Commons Attribution 3.0 Unported (CC BY 3.0)

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Adaptation of endovascular technique of self-expandable metal esophageal stent implantation in palliative treatment of malignant dysphagia in the course of esophageal and bronchial cancers: A one-center study

Damian Ziaja1,2,B, Bartłomiej Stasiów3,B, Mariola Sznapka2,B, Jolanta Domalik4,B, Wacław Kuczmik2,E, Krzysztof Ziaja2,A,E, Jerzy Chudek5,F

1 Department of Physiotherapy, Faculty of Health Sciences in Katowice, Medical University of Silesia in Katowice, Poland

2 Department of Department of General and Vascular Surgery, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, Poland

3 Department of Radiology, Upper-Silesian Medical Centre in Katowice of Medical University of Silesia in Katowice, Poland

4 Department of General, Vascular and Transplant Surgery, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, Poland

5 Department of Internal Diseases and Oncological Chemotherapy, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, Poland

Abstract

Background. Esophageal stent implantation is an alternative for microjejunostomy or total parenteral nutrition in the palliative treatment of malignant dysphagia in the course of esophageal and advanced bronchial cancers infiltrating the esophagus. The procedure of implanting an esophageal self-expanding metal stent (SEMS) is performed with gastroscopic guidance under general anesthesia.
Objectives. To analyze the efficacy and safety of a simplified technique (without gastroscopic guidance in local anesthesia) of esophageal SEMS implantation in patients with malignant dysphagia in the course of esophageal and bronchial cancers.
Material and Methods. This is a retrospective analysis of consecutive procedures of uncovered esophageal SEMS implantation performed with a simplified adaptation of the endovascular technique (Seldinger wire) in patients with esophageal and bronchial cancers and poor performance status. The procedures were done in a single surgical center over an 8-year period in 27 patients who were referred from oncology departments with esophageal stenosis confirmed using gastroscopy and who were being treated for malignant dysphagia. The study endpoints were effectiveness (a decrease in dysphagia from grade 3 or 4 to grade 1 after the procedure) and complications related to the procedures (including restenosis and stent migration).
Results. In all 27 patients, the SEMS were effectively implanted, enabling enteral nutrition after the procedure. No early complications related to the procedure were observed. A single patient developed restenosis 14 days after the procedure, which required re-stenting.
Conclusion. The simplified method for SEMS implantation described herein may be considered an option in the palliative treatment of patients with malignant dysphagia in the course of esophageal and bronchial cancers and poor performance status, especially in facilities with limited access to endoscopy.

Key words

esophageal cancer, bronchial cancer, self-expandable metal esophageal stent implantation, malignant dysphagia, palliative treatment

References (13)

  1. Watt E, Whyte F. The experience of dysphagia and its effect on the quality of life of patients with esophageal cancer. Eur J Cancer Care (Engl). 2003;12(2):183–193.
  2. Anandavadivelan P, Lagergren P. Cachexia in patients with esophageal cancer. Nat Rev Clin Oncol. 2016;13(3):185–198.
  3. Martinez JC, Puc MM, Quiros RM. Esophageal stenting in the setting of malignancy. ISRN Gastroenterology. 2011;2011:719575.
  4. Reed CE, Marsh WH, Carlson LS, at al. Prospective, randomized trial of palliative treatment for unresectable cancer of the esophagus. Ann Thorac Surg. 1991;51(4):552–555.
  5. Dormann AJ, Eisendrath P, Wigginghaus B, Huchzermeyer H, Devière J. Palliation of esophageal carcinoma with a new self-expanding plastic stent. Endoscopy. 2003;35(3):207–211.
  6. Madhusudhan C, Saluja SS, Pal S, et al. Palliative stenting for relief of dysphagia in patients with inoperable esophageal cancer: Impact on quality of life. Dis Esophagus. 2009;22(4):331–336.
  7. Zhang K, Wei S, Wu J, Li C, Ma X, Wang Q. Palliation of malignant esophageal obstruction and fistulas with covered self-expandable metallic stents: Assessment of a simple fluoroscopic method. Int J Clin Exp Med. 2015;8(6):8860–8865.
  8. Dai Y, Li C, Xie Y, et al. Interventions for dysphagia in esophageal cancer. Cochrane Database Syst Rev. 2014;10:CD005048.
  9. Homs MY, Steyerberg EW, Eijkenboom WM, et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from esophageal cancer: Multicentre randomised trial. Lancet. 2004;364(9444):1497–1504.
  10. Bergquist H, Johnsson E, Nyman J, et al. Combined stent insertion and single high-dose brachytherapy in patients with advanced esophageal cancer: Results of a prospective safety study. Dis Esophagus. 2012;25(5):410–415.
  11. Zhu HD, Guo JH, Mao HW, et al. Conventional stents versus stents loaded with 125iodine seeds for treatment of unresectable esophageal cancer: A multicentre, randomized phase 3 trial. Lancet Oncol. 2014;15(6):612–619.
  12. Lee S, Osugi H, Tokuhara T, et al. Self-expandable metallic stent for unresectable malignant strictures in the esophagus and cardia. Jpn J Thorac Cardiovasc Surg. 2005;53(9):470–476.
  13. Hindy P, Hong J, Lam-Tsai Y, Gress F. A comprehensive review of eso­phageal stents. Gastroenterol Hepatol (NY). 2012;8(8):526–532.
© Wroclaw Medical University